NCT04270344View on ClinicalTrials.gov

The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

UnknownOBSERVATIONAL

Enrollment

905

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Hypercholesterolemia

Interventions

DRUG

Pitavastatin 4mg

combination therapy with pitavastatin/valsartan (LivaloV)

Trial Locations (1)

Unknown

RECRUITING

JWP, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY